Pharmaceutical Investing M Pharmaceutical Inc. Provides Strategic Report to Shareholders Highlighting Acquisitions and Product Development
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor